Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Ovarian carcinomas with genetic and epigenetic BRCA1 loss have distinct molecular abnormalities

22 Jan 2008

Abstract excerpt

BACKGROUND: Subclassification of ovarian carcinomas can be used to guide treatment and determine prognosis. Germline and somatic mutations, loss of heterozygosity (LOH), and epigenetic events such as promoter hypermethylation can lead to decreased expression of BRCA1/2 in ovarian cancers. The mechanism of BRCA1/2 loss is a potential method of subclassifying high grade serous carcinomas. METHODS: A consecutive...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA gene mutations in cancer
Share to Ovarian cancer diagnosis and treatment
Share to PARP inhibition in cancer therapy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 18208621
DOI: 10.1186/1471-2407-8-17

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Ovarian carcinomas with genetic and epigenetic BRCA1 loss have distinct molecular abnormalitiesPMID 18208621Read ↗

BRCA1 and BRCA2 mutations correlate with TP53 abnormalities and presence of immune cell infiltrates in ovarian high-grade serous carcinoma.Semantic proximity Read ↗

BRCA1 Immunohistochemistry in a Molecularly Characterized Cohort of Ovarian High-Grade Serous CarcinomasSemantic proximity Read ↗

Ovarian carcinomas: at least five different diseases with distinct histological features and molecular genetics.Semantic proximity Read ↗

Critical molecular abnormalities in high-grade serous carcinoma of the ovary.Semantic proximity Read ↗

The genesis and evolution of high-grade serous ovarian cancer.Semantic proximity Read ↗

Histologic, molecular, and cytogenetic features of ovarian cancers: implications for diagnosis and treatment.Semantic proximity Read ↗

Genetic and molecular changes in ovarian cancerSemantic proximity Read ↗

Minireview: Human Ovarian Cancer: Biology, Current Management, and Paths to Personalizing TherapySemantic proximity Read ↗

Ovarian carcinoma: pathology review with an emphasis in their molecular characteristicsSemantic proximity Read ↗

Molecular pathology of ovarian cancer.Semantic proximity Read ↗

The Changing View of High-Grade Serous Ovarian CancerSemantic proximity Read ↗

Low-grade serous ovarian carcinoma: an evolution toward targeted therapy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.